Literature DB >> 10416746

Vascular aspects in the pathophysiology of glaucomatous optic neuropathy.

H S Chung1, A Harris, D W Evans, L Kagemann, H J Garzozi, B Martin.   

Abstract

Glaucoma remains a major eye illness with unknown etiology. Although elevated intraocular pressure is clearly a major risk factor, vascular deficits may contribute to initiation and progression of glaucoma. When intraocular pressure is acutely elevated in healthy individuals, the resistance index (derived from the peak systolic and end-diastolic velocities and an indirect index of vascular resistance distal to the site of measurement) in the central retinal and posterior ciliary arteries increases progressively. This result implies that mechanical and vascular factors may be coupled in such a way that perfusion of the retina and optic nerve head may be influenced by changes in the intraocular pressure. Further, at night, when ophthalmic artery flow velocities fall as arterial blood pressure falls in glaucoma patients, the risk of disease progression may be increased. The constancy of these same flow velocities in age-matched healthy individuals points to a possible vascular autoregulatory defect in glaucoma. In addition, in normal-tension glaucoma, vasodilation (CO2 inhalation) normalizes retrobulbar arterial flow velocities, hinting that some vascular deficits in glaucoma may be reversible. Finally, Ca2+ channel blockade improves contrast sensitivity in patients with normal-tension glaucoma, who also show increased retrobulbar vessel flow velocities, a result suggesting that visual function loss may be linked to ocular ischemia. Emerging evidence points to a role of ischemia in the pathogenesis of glaucoma, suggesting that treatments designed to improve ocular blood flow may benefit glaucoma patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416746     DOI: 10.1016/s0039-6257(99)00050-8

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  53 in total

1.  Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma.

Authors:  Efstathios T Detorakis; Athanassios K Achtaropoulos; Eleni E Drakonaki; Vassilios P Kozobolis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

2.  Contribution to ischemic injury of rat optic nerves by intracellular sodium overload.

Authors:  Cun-Jian Dong; William A Hare
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

3.  Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells.

Authors:  G Tezel; M B Wax
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Repeatability and reproducibility of optic nerve head perfusion measurements using optical coherence tomography angiography.

Authors:  Chieh-Li Chen; Karine D Bojikian; Chen Xin; Joanne C Wen; Divakar Gupta; Qinqin Zhang; Raghu C Mudumbai; Murray A Johnstone; Philip P Chen; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2016-06-01       Impact factor: 3.170

5.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

6.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

7.  Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.

Authors:  Kelvin Yoon Chiang Lee; Mao Nakayama; Makoto Aihara; Yi-Ning Chen; Makoto Araie
Journal:  Mol Vis       Date:  2010-02-17       Impact factor: 2.367

8.  Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.

Authors:  Rajkumar Tulsawani; Lorena S Kelly; Nigar Fatma; Bhavanaben Chhunchha; Eri Kubo; Anil Kumar; Dhirendra P Singh
Journal:  BMC Neurosci       Date:  2010-10-05       Impact factor: 3.288

Review 9.  Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  Risto S Cvetkovic; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells.

Authors:  Yuan He; Kar Wah Leung; Ye-Hong Zhuo; Jian Ge
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.